During this time, the institute has established itself as world-leading in improving our understanding of underlying disease mechanisms and has formed a series of strategic partnerships, including with LifeArc and the British Heart Foundation.
The institute’s scientific excellence was recognised in 2022 by a panel of international experts and peers, which awarded it a score of excellent in its first major review. As a result, the Medical Research Council has committed £131m as part of a collective commitment with our other founding funders of £150 million for the next five years.
Dr Adrian Ivinson says:
“From day one, the bedrock of the UK DRI has been the highest quality discovery science. As the COO I have used that ambition as my north star with everything else we do, serving that singular aim. Six short years later I am immensely proud of what we have all achieved: 800+ researchers, at seven well-appointed centres, working at the very highest level to better understand the causes or neurodegeneration and to turn that understanding into interventions that people affected by dementia value. I wish the UK DRI a fair wind and ongoing success in its quest to improve the lives of all those affected by neurodegeneration.”
William Rucker, Chair of the UK DRI, says:
“After over 6 years of outstanding service, Adrian Ivinson will be leaving the UK DRI at the end of November 2023. The Board of Trustees share my personal gratitude to Adrian for all he has done in his operational leadership role at the institute, working with former Institute Director Bart de Strooper to build a world-leading neuroscience research institute which is now firmly embedded in the UK and global neuroscience ecosystem. We wish him the very best for the future.”
Prof Siddharthan Chandran, Director of the UK DRI, says:
“In a short time, the UK DRI from a standing start has become the science discovery engine that underpins the entire UK dementia ecosystem. This singular achievement reflects in no small part the combination of my predecessor Bart De Strooper’s scientific vision allied with the operational gifts of Adrian Ivinson in implementing this strategy across our six host universities. As a result, the UK DRI is very well placed, in our next phase, to drive impactful science that will make a difference to the lives of people at risk or living with dementia. I wish Adrian the very best.”
Article published: 24 November 2023
Banner image: Copyright UK DRI Ltd